Financials

  • Market Capitalization 42.72 M
  • Employee 82
  • Founded 2018
  • CEO N/A
  • Website www.aligos.com
  • Headquarter Delaware, United States
  • FIGI BBG00QX7QH68
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.8
Rapporto prezzo/fatturato
21

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4305
VERU
Veru Inc. - Common Stock
2.63 USD-4.01%-0.38%+17.41%+10.04%44.84 M USD
4319
MREO
Mereo BioPharma Group plc - American Depositary Shares
0.25 USD-7.41%-13.79%-19.35%-85.71%39.92 M USD
4325
KPTI
Karyopharm Therapeutics Inc. - Common Stock
1.88 USD-3.09%-4.08%-73.30%-80.50%42.64 M USD
4341
ACTU
Actuate Therapeutics, Inc. - Common stock
1.67 USD-1.18%+31.50%+53.21%-59.07%40.10 M USD

Notizie